Our experiments further demonstrated that inhibiting the xCT-GSH-GPX4 pathway can synergistically enhance disulfiram/copper (DSF/Cu)-induced cuproptosis in myelodysplastic syndrome [191]. The gene discussed is SLC7A11; the disease is myelodysplastic syndrome.